Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Autoimmunity 2019

About Conference


Conference Series Ltd invites all the participants across the world to attend “International Congress on Autoimmunity’’ during March 17-18, 2019 in Brisbane, Australia which includes oral, keynote presentations, Poster presentations and ExhibitionsThe conference highlights the theme: Unveiling the versatile therapies to achieve breakthrough in Immunity. Conferences Series organizes a 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in Middle East, Asia, Europe and USA with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Autoimmunity 2019 is the only meeting where you can learn about autoimmune diseases from a variety of perspectives, both research-based and clinical. We will discuss the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research on genetic, etiology, diagnostic, clinical aspects and novel therapies of autoimmune diseases. Autoimmunity Conferences provides the time to collaborate with industry peers and discover knowledge and resources that can be used to achieve your personal and organizational goals

Why to attend?

Autoimmunity is a platform for, (Doctors, physicians, research scholars, students, industrial and pharma professionals) to expose their research work, to Share their knowledge in immunity diseases. It is an opportunity to interact with members across the globe focused on learning about Immunology. World renowned speakers, the most recent therapies and the latest updates in Autoimmunity for Immunology are hallmarks of this conference.

Target Audience:

· Allergists

· Immunologists

· Microbiologists

· Pediatricians

· Physicians

· Academicians

· Health Care professionals

· Young Research Scholars

· Students

· Society & Organizational Members

Scientific Sessions

Track 1: Autoimmune Diseases: One of the functions of the immune system is to protect the body by responding to invading microorganisms, such as viruses or bacteria, by producing antibodies or sensitized lymphocytes (types of white blood cells). Under normal conditions, an immune response cannot be triggered against the cells of one's own body. In some cases, however, immune cells make a mistake and attack the very cells that they are meant to protect. This can lead to a variety of autoimmune diseases. They encompass a broad category of related diseases in which the person's immune system attacks his or her own tissue.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track 2: Molecular Immunology: The study of the molecular and cellular components that comprise the immune system, including their function and interaction, is the central science of immunology. The immune system has been divided into a more primitive innate immune system and, in vertebrates, an acquired or adaptive immune system.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences:

Annual Meeting of the Dutch Society for Immunology, December 13-14, 2017, Netherlands; Immune Deficiency and Dysregulation North American Conference, April 26 – 29, 2018, Toronto, Canada; Immunology 2018, May 4-8, 2018, Austin, Texas; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 5th International Conference on Parasitology, July 12-13, 2018 Paris, France; 10th International Conference on Clinical and Cellular Immunology, August 6-7, 2018 Madrid, Spain; 5th European Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29th Annual Conference of the Australasian Society of Clinical Immunology and Allergy, September 4-8, 2018, Canberra, Australia;

Track 3: Cancer and Autoimmunity: Cancer immunology is division of biology which deals with understanding the role of the immune system in the development of cancer and string. The most well notable application in cancer immunology is cancer immunotherapy which taps the immune system as a treatment for cancer. Cancer immunologic surveillance and immune editing is based on immunity against development of automatic and chemically promote tumors in identification of targets animal systems and for immune recognition of human cancer.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences:

3rd International Conference on Tumor & Cancer Immunology and Immunotherapy, September 17-18, 2018 San Diego, USA | 3rd Edition of International Conference on Colorectal cancer, October 11-12, 2018, Zurich-Switzerland | 3rd International Cancer Study & Therapy Conference, May 02 - May 04, 2018, Rome, Italy | 3rd World Congress and Expo on Immunology, October 18-20, 2018 at Amsterdam, Netherlands |10thAnnual Immunology Congress, August 28-29, 2018, Athens, Greece | Cancer Conference 2018, March 19-21, 2018 Valencia, Spain | 30th World Congress on Vaccines and Immunization, October 22-23, 2018 Osaka, Japan.

Track 4: Therapy of Autoimmune Liver Disease: The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. Treatment of this autoimmune liver disease should also address various symptoms and complications arising from any associated autoimmune diseases, particularly cholestasis and cirrhosis-related complications. For primary sclerosing cholangitis there are no established immunomodulatory therapies, but medical, endoscopic, and surgical treatments are applicable to this disease. Liver transplantation becomes indicated during the eventual end stages of each of these immune-mediated liver diseases.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences:

8th Global Summit on Neuroscience and Neuroimmunology, August 6-7, 2018Madrid, Spain; 20th World Congress on Nutrition & Food Sciences, May 14-16, 2018, Tokyo, Japan;11th World Microbiology & Immunology Congress, June 28-29, 2018, Amsterdam, Netherlands;9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track 5: New Cytokines and Anti-Cytokines: Cytokines which comprise of a family of proteins--interleukins, lymphokines, monokines, interferons, and chemokines, are important components of the immune system. They act in concert with specific cytokine inhibitors and soluble cytokine receptors to regulate the human immune response. Their physiologic role in inflammation and pathologic role in systemic inflammatory states are now well recognized. An imbalance in cytokine production or cytokine receptor expression and/or dysregulation of a cytokine process contributes to various pathological disorders. Research is progressing rapidly in the area of cytokines and their therapeutic targets, the two major therapeutic modalities being the administration of purified recombinant cytokines and the use of their antagonists in various inflammatory disorders. However, given the large number of cytokines, it is disappointing that only relatively few can be used clinically.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track 6: Novel Therapeutic Targets: Autoimmunity results from a break in self-tolerance involving humoral and/or cell-mediated immune mechanisms. One pathological consequence of a failure in central and/or peripheral tolerance is the generation of autoantibodies and subsequent formation of complement-fixing immune complexes that contribute to tissue damage. Prevailing pharmacological strategies for treating autoimmune diseases involve the use of broad-acting immunosuppressants that with long term use have associated toxicities. The current drive in drug development is towards therapies that target a specific biological pathway or pathogenic cell population. Recent discovery of the BAFF-mediated B-cell survival pathway provides a unique opportunity for developing focused intervention for autoreactive B-cell function.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences:

8th Global Summit on Neuroscience and Neuroimmunology, August 6-7, 2018Madrid, Spain; 20th World Congress on Nutrition & Food Sciences, May 14-16, 2018, Tokyo, Japan;11th World Microbiology & Immunology Congress, June 28-29, 2018, Amsterdam, Netherlands;9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track 7: Genetics and Epigenetics: Self-tolerance loss is fundamental to autoimmunity. While understanding of immune regulation is expanding rapidly, the mechanisms causing loss of tolerance in most autoimmune diseases remain elusive. Autoimmunity is believed to develop when genetically predisposed individuals encounter environmental agents that trigger the disease. Recent advances in the genetic and environmental contributions to autoimmunity suggest that interactions between genetic elements and epigenetic changes caused by environmental agents may be responsible for inducing autoimmune disease.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30, 2018 Valencia, Spain; Hynes Convention Center, March 4–7, 2018, Boston, Massachusetts; 2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS, October 17-18, 2018, Las Vegas, Neveda ,USA; 2nd International Conference & Expo on HIV & AIDS, September 17-18, 2018, Toronto, Canada; International Workshop on HIV & Women, March 2-7, 2018, Boston; 3rd International Conference on Autoimmunity, November 26-27, 2018, Dublin, Ireland

Track 8: Infection and Autoimmunity: Virus infection is a primary factor that has been implicated in the initiation of autoimmune disease. Infection triggers a robust and usually well-coordinated immune response that is critical for viral clearance. However, in some instances, immune regulatory mechanisms may falter, culminating in the breakdown of self-tolerance, resulting in immune-mediated attack directed against both viral and self-antigens. Traditionally, cross-reactive T-cell recognition, known as molecular mimicry, as well as bystander T-cell activation, culminating in epitope spreading, have been the predominant mechanisms elucidated through which infection may culminate in an T-cell-mediated autoimmune response.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track 9: Translational Immunology: Translational immunology is the process by which researchers use immunological discoveries to develop practical solutions for human problems. Examples include the development of vaccines against infectious diseases or the engineering of new types of drugs to treat inflammatory disorders.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track 10: Complement in Autoimmunity: The complement system is an ancient and evolutionary conserved element of the innate immune mechanism. It comprises of more than 20 serum proteins most of which are synthesized in the liver. These proteins are synthesized as inactive precursor proteins which are activated by appropriate stimuli. The activated forms of these proteins act as proteases and cleave other components successively in amplification pathways leading to exponential generation of final effectors. Three major pathways of complement pathways have been described, namely the classical, alternative and lectin pathways which are activated by different stimuli.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

9th Molecular Immunology & Immunogenetics Congress, March 08-09, 2018; 10th World Congress and Expo on Immunology, October 19-20, 2018 Baltimore, USA; 7th World Congress on Immunology, April 19-20, 2018, Amsterdam, Netherlands;10th International Conference on Orthopedics, Trauma & Rheumatology, March 08-09, 2018London, UK;39th Annual congress on Microbe Infection, October 29-30, 2018, Valencia, Spain; 11th International Congress on Autoimmunity, May 16-20, 2018, Lisbon, Portugal;5th International Congress on Infectious Diseases, March 01-02, Berlin, Germany;3rd Annual Prevent and Reverse Heart Disease and Auto Immune Disease for Women, March 10, 2018, United States.

Track 11: Low Dose Naltrexone & Autoimmune Conditions: There is growing recognition in the scientific community that autoimmune diseases result from immunodeficiency, which disturbs the ability of the immune system to distinguish "self" from "non-self". The normalization of the immune system induced by LDN makes it an obvious candidate for a treatment plan in such diseases.The experience of people who have autoimmune diseases and who have begun LDN treatment has been remarkable. Patients with diagnoses such as systemic lupus, rheumatoid arthritis, Behcet's syndrome, Wegener's granulomatosis, bullous pemphigoid, psoriasis, and Crohn's disease have all benefited.Because LDN clearly halts progression in multiple sclerosis, its use has been more recently extended to other neurodegenerative diseases, such as Parkinson's disease and amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) whose etiology remains unknown but for which there is suggestive evidence of a possible autoimmune mechanism.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30, 2018 Valencia, Spain; Hynes Convention Center, March 4–7, 2018, Boston, Massachusetts; 2nd International Conference on Sexually Transmitted Diseases, Infections and AIDS, October 17-18, 2018, Las Vegas, Neveda ,USA; 2nd International Conference & Expo on HIV & AIDS, September 17-18, 2018, Toronto, Canada; International Workshop on HIV & Women, March 2-7, 2018, Boston; 3rd International Conference on Autoimmunity, November 26-27, 2018, Dublin, Ireland

Track 12: Prediction, Monitoring and Prevention: forecast the outcome of therapy in clinical trials, or aid in developing improved treatments or preventative measures. All of these applications have been applied to the autoimmune diseases. As a case in point, we have through the years used biomarkers to predict susceptibility and the longer-range outcome of thyroid autoimmunity employing, a number of different approaches. They have taught us valuable lessons for future broader applications of biomarkers. The clues for susceptibility include major histocompatibility complex (MHC) and non-MHC genes combined with the fine specificity of thyroid autoantibodies in siblings of patients with juvenile thyroid disease. Together these biomarkers are highly predictive of later thyroid autoimmunity and subclinical thyroid dysfunction. For example, the progression from benign autoimmunity to clinical thyroid disease is marked by the appearance of autoantibodies to species-restricted epitopes on thyroglobulin. Thus, predictive biomarkers aid in identifying individuals with inordinate risk of disease and provide opportunities for earlier interventions to arrest the disease process.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences:

8th Global Summit on Neuroscience and Neuroimmunology, August 6-7, 2018Madrid, Spain; 20th World Congress on Nutrition & Food Sciences, May 14-16, 2018, Tokyo, Japan;11th World Microbiology & Immunology Congress, June 28-29, 2018, Amsterdam, Netherlands;9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track 13: Stem Cell Therapy in Autoimmune Diseases: Biomarkers, represented by genetically determined traits or biologic changes predictive of disease onset or outcome, are increasingly employed by academic and industrial investigators. They can identify unusually susceptible populations or individuals, facilitate prognosis, Currently, autoimmune conditions are treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade). Despite inducing temporary improvement, these approaches possess the possibility of long-term adverse effects, as well as need for life-long treatment.

Stem cell therapy has been demonstrated to induce profound healing activity in animals with various forms of autoimmune disorders. Besides healing damaged tissues, stem cells have the unique ability to modulate the immune system so as to shut off pathological responses while preserving its ability to fight off disease. Stem cells and specifically, mesenchymal stem cells home to inflamed tissue and start producing anti-inflammatory agents. These mediators act locally and do not suppress the immune response of the patient’s whole body. Additionally, mesenchymal stem cells induce the production of T regulatory cells, a type of immune cell whose function is to protect the body against immunological self-attack.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

Annual Meeting of the Dutch Society for Immunology, December 13-14, 2017, Netherlands; Immune Deficiency and Dysregulation North American Conference, April 26 – 29, 2018, Toronto, Canada; Immunology 2018, May 4-8, 2018, Austin, Texas; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 5th International Conference on Parasitology, July 12-13, 2018 Paris, France; 10th International Conference on Clinical and Cellular Immunology, August 6-7, 2018 Madrid, Spain; 5th European Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29th Annual Conference of the Australasian Society of Clinical Immunology and Allergy, September 4-8, 2018, Canberra, Australia; Annual Congress on Immunology & Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy; September 17-18, 2018 San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rd International Conference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rd Antibodies and Bio Therapeutics Congress & B2B, November 08-09, 2017 Las Vegas, Nevada, USA.

Track 14: Thyroid Autoimmunity: Also called Hashimoto's disease, Hashimoto's thyroiditis is an autoimmune disease, a disorder in which the immune system turns against the body's own tissues. In people with Hashimoto's, the immune system attacks the thyroid. ... Located in the front of your neck, the thyroid gland makes hormones that control metabolism.

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences:

8th Global Summit on Neuroscience and Neuroimmunology, August 6-7, 2018Madrid, Spain; 20th World Congress on Nutrition & Food Sciences, May 14-16, 2018, Tokyo, Japan;11th World Microbiology & Immunology Congress, June 28-29, 2018, Amsterdam, Netherlands;9th European Immunology Conference, June 14-16, 2018, Rome, Italy; 3rd International Conference on Cancer Immunology and Immunotherapy, September 17-18, 2018, San Diego, USA; 5th International Conference on Parasitology, July 12-13, 2018; Paris, France; 3rd International Conference on Tumor Immunology and Immunotherapy, September 17-18, 2018; San Diego, USA.

Track 15: Peptides and Autoimmune Diseases: Several self-molecules have been identified as target antigens in autoimmune diseases. Since lack or loss of tolerance to these molecules is one of the key events promoting autoimmunity, researchers are exploring the possibility that the administration of antigens or peptides may stimulate tolerogenic mechanisms and delay or prevent the full phenotypic expression of autoimmune diseases. There is much enthusiasm for such therapies, as these will probably be disease-specific and not associated with the side effects of conventional immunosuppression

Related Autoimmunity ConferencesAutoimmunity MeetingsImmunology Conferences |Autoimmune Disease Conferences

Annual Meeting of the Dutch Society for Immunology, December 13-14, 2017, Netherlands; Immune Deficiency and Dysregulation North American Conference, April 26 – 29, 2018, Toronto, Canada; Immunology 2018, May 4-8, 2018, Austin, Texas; 9th European Immunology Conference, June 14-16, 2018 Rome, Italy; 5th International Conference on Parasitology, July 12-13, 2018 Paris, France; 10th International Conference on Clinical and Cellular Immunology, August 6-7, 2018 Madrid, Spain; 5th European Congress of Immunology, September 2-5, 2018, Amsterdam, Netherlands; 29th Annual Conference of the Australasian Society of Clinical Immunology and Allergy, September 4-8, 2018, Canberra, Australia; Annual Congress on Immunology & Immunotechnology, September 13-14, 2018 Zurich, Switzerland; 3rd International Conference on Tumor & Cancer Immunology and Immunotherapy; September 17-18, 2018 San Diego, USA; 12th International Conference on Allergy, Asthma & Clinical Immunology, October 1-2, 2018 Moscow, Russia; 3rd International Conference on Autoimmunity, November 26-27, 2018 Dublin, Ireland; 3rd Antibodies and Bio Therapeutics Congress & B2B, November 08-09, 2017 Las Vegas, Nevada, USA.

Market Analysis

One of the functions of the immune system is to protect the body by responding to invading microorganisms, such as viruses or bacteria, by producing antibodies or sensitized lymphocytes (types of white blood cells). Under normal conditions, an immune response cannot be triggered against the cells of one's own body. In some cases, however, immune cells make a mistake and attack the very cells that they are meant to protect. This can lead to a variety of autoimmune diseases. They encompass a broad category of related diseases in which the person's immune system attacks his or her own tissue.

Importance and Scope:

International congress on Autoimmunity offers a premier forum for discussions and debates, in this fascinating interdisciplinary field of Immunology, Molecular biology, Molecular medicine, Microbiology which are centralizing & consolidating their respective discoveries and advances

  • Discuss emerging issues in Immunology, Molecular Biology
  • Discuss and apply recent research findings related to Molecular Immunology
Market value on Autoimmunity Research:
 
The Global revenues for Autoimmunity 2019 market is estimated at $62.57 billion in 2016 and is expected to reach $160.24 billion by 2023 growing at a CAGR of 14.3% from 2016 to 2023.
The Australia Autoimmunity 2019 Market was worth $28.52 Billion in 2016 and estimated to reach $50.71 Billion by the end of 2023 with a growing potential of 12.20 %. 
The Europe Autoimmunity 2019 Market was estimated to reach $23.41 Billion by the end of 2023 with a growing potential of 12.45 %.
Asia Pacific Autoimmunity 2019 market is expecting a sound growth of CAGR of 15.5% during the forecasted period 2017-2023.
The LAMEA (Latin America, Middle East & Africa) Autoimmunity 2019 Market is expecting a sound growth of 17.9% CAGR during the forecast period (2017 – 2023).
 
Growth Rate of Immunology:
 
 
Precision Medicine Market:
The medicine market accounted for $43.59 billion in 2016 and is estimated to reach $141.70 billion by 2026. The market is expected to grow at a compound annual growth rate (CAGR) of 11.23% between the years 2017 and 2026.
The Europe precision medicine market was valued at around USD 33,200.0 million in the year 2014 and it is expected to reach approximately USD 35,500.0 million by 2024. The Europe precision medicines market is expected to exhibit a CAGR of more than13% between 2017 and 2025.
Asia-Pacific Precision Medicine Market is estimated to grow at a CAGR of 12.4% during the forecasted period. Japan accounted for the largest market share in 2015, with a market value of USD 1.30 billion and is projected to grow at a CAGR of 11.4% during the forecast period.
The Latin America Precision Medicine market has been estimated at USD 4.05 Billion in 2016 and is projected to reach USD 7.23 Billion by 2021, at a CAGR of 12.3% during the forecast period from 2016 to 2025.
 
Major Universities on Immunology Research:
 
University of Melbourne
Monash University
University of New South Wales
University of Queensland Australia
University of Sydney
University of Western Australia
Australian National University
 
Pharma companies:
 
Roche Products PTY Ltd
LEO Pharma
Luina Bio
Sanofi Consumer Healthcare
Tripak Pharmaceuticals
Invion Limited
Sigma Co.
Mylan
BJP Laboratories
Perrigo Australia
Australia Natural Pharmaceutical Group Pty Ltd

 

Past Conference Report

Immunobiology-2018

10th Global Summit on Immunology and Cell biology

Immunobiology-2018 past Conference Report

10th Global summit on Immunology and Cell Biology" will be held from May 11-12, 2017 Osaka Japan which incorporates incite keynote introductions, Oral talks, Poster introductions, Young Researchers gathering and Exhibitions. 

Immunology Conference is to get-together individuals in the scholarly community and society keen on immunology to share the most recent patterns and imperative issues important to our field/branch of knowledge. Immunology and Cell science Conference unites the worldwide pioneers in Immunology and significant fields to display their exploration at this restrictive logical program. The Immunology occasions have introductions from editors of conspicuous refereed diaries, famous and dynamic examiners and chiefs in the field of Immunology. Immunology Conference Organizing Committee additionally welcomes Young agents at each profession stage to submit abstracts announcing their most recent logical discoveries in oral and publication sessions. The meeting will incorporate welcomed speakers, oral introductions, publication session and the youthful researcher grant. Gathering Series sorts out 1000+ Global Events comprehensive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia with help from 1000 more logical social orders and distribute 700+ Open access diaries which contain more than 30000 famous identities, rumored researchers as publication board individuals.

The Immunobiology-2018Conference was carried out through various sessions with discussions on the following thought provoking major scientific tracks:

Allergy & Clinical Immunology 
Immunoncology & Molecular Immunology
Medicine Immunology & Immunohematology
Immunogenetics & Histocompatibility
Cancer Immunology & Immunotherapy
Innate & adaptive Immunity
Vaccines & Vaccination
Pediatric Immunology & Health care
Immunopathology
Immunology & Diabetes
Autoimmunity & Immune Responses
Reproductive Immunology
Nutritional Immunology
Transplantation Immunology
Molecular & Cellular microbiology

The conference was embarked with an opening ceremony followed by Keynote presentations, Workshop and a series of lectures delivered by both honorable guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

1.Session Chairs:

 Qiong Ma, Fourth Military Medical University, China

 Bibigul Ilyassova, Syzganov National Scientific Center of Surgery, Kazakhstan

2. Keynote Presentations

Adeyemi Abati, Lagos University, Nigeria

Zhi-Zhang Yang, Mayo Clinic, USA

Bibigul Ilyassova, Syzganov National Scientific Center of Surgery, Kazakhstan

3.Sessions talks

Kinga Majchrzak, Warsaw University of Life Sciences, Poland

Joanna K Bujak, Warsaw University of Life Sciences, Poland

Qiong Ma, Fourth Military Medical University, China

Caitlin D Bohannon, Centers for Disease Control and Prevention, USA

Nasser Hashemi Goradel, Tehran University of Medical Sciences, Iran

Sheila Cabezas, Flinders University, Australia

Teppei Kitagawa, Beckman Coulter, Japan

Ahmed Abd El Rahman Daoud, Tanta University, Egypt

Your rejoinder is our inspiration, keeping this motto in mind and being witnessed the triumph of Immunobiology-2018, Conference Series LLC is delighted to announce the next event, “International Congress on Autoimmunity” to be held during March 17-18, 2019 , Brisbane, Australia.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 17-18, 2019

Speaker Opportunity

Supported By

Journal of Clinical & Cellular Immunology Immunome Research Journal of Allergy & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by